Panel Discussion: Current Efforts to Spearhead Regulatory Modernisation & Acceptance of Novel CGT Technologies

• Share how regulators in Europe, the US, and Asia are adapting frameworks to keep pace with emerging cell and gene therapy technologies
• Highlight initiatives that foster earlier and more constructive engagement
• Understand how modernisation efforts can accelerate approvals, support broader adoption, and make CGTs more commercially viable

Speakers:

Albeena Nisar

Scientific, Car T Cell Therapy Centre & cGMP Cell Therapy Unit Project Officer

Tata Memorial Centre

Mohamed Awwad

Group Leader

Heidelberg University Hospital

Anna Litsiou

Director Regulatory Policy & Intelligence

AstraZeneca